Publikationen in Zusammenarbeit mit Forschern von Icahn School of Medicine at Mount Sinai (13)

2024

  1. OMERACT systemic lupus erythematosus domain survey

    Seminars in Arthritis and Rheumatism, Vol. 68

2023

  1. Droplet-based bisulfite sequencing for high-throughput profiling of single-cell DNA methylomes

    Nature communications, Vol. 14, Núm. 1, pp. 4672

2017

  1. Antipsychotic-induced Hdac2 transcription via NF-ΰ B leads to synaptic and cognitive side effects

    Nature Neuroscience, Vol. 20, Núm. 9, pp. 1247-1259

2016

  1. Allosteric signaling through an mGlu2 and 5-HT2A heteromeric receptor complex and its potential contribution to schizophrenia

    Science Signaling, Vol. 9, Núm. 410

2014

  1. Evaluation of 5-HT2A and mGlu2/3 receptors in postmortem prefrontal cortex of subjects with major depressive disorder: Effect of antidepressant treatment

    Neuropharmacology, Vol. 86, pp. 311-318

2013

  1. Dysregulated 5-HT2A receptor binding in postmortem frontal cortex of schizophrenic subjects

    European Neuropsychopharmacology, Vol. 23, Núm. 8, pp. 852-864

2012

  1. HDAC2 regulates atypical antipsychotic responses through the modulation of mGlu2 promoter activity

    Nature Neuroscience, Vol. 15, Núm. 9, pp. 1245-1254

  2. Identification of three residues essential for 5-hydroxytryptamine 2A-metabotropic glutamate 2 (5-HT2A·mGlu2) receptor heteromerization and its psychoactive behavioral function

    Journal of Biological Chemistry, Vol. 287, Núm. 53, pp. 44301-44319

2010

  1. α2-adrenoceptor functionality in postmortem frontal cortex of depressed suicide victims

    Biological Psychiatry, Vol. 68, Núm. 9, pp. 869-872

2008

  1. Identification of a serotonin/glutamate receptor complex implicated in psychosis

    Nature, Vol. 452, Núm. 7183, pp. 93-97

  2. alpha(2)-Adrenoceptors and Coupled Systems: Changes in Major Depression and Modulation by Antidepressant Drugs

    METHODS AND FINDINGS IN EXPERIMENTAL AND CLINICAL PHARMACOLOGY

2006

  1. Heterotrimeric G proteins: Insights into the neurobiology of mood disorders

    Current Neuropharmacology, Vol. 4, Núm. 2, pp. 127-138

2002

  1. Quantitative stoichiometry of G-proteins activated by μ-opioid receptors in postmortem human brain

    European Journal of Pharmacology, Vol. 452, Núm. 1, pp. 21-33